BAL PHARMA
Back to Income Statement
|
BAL PHARMA Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Consolidated Net Profit | ₹2.57 Cr | ₹5.61 Cr | ₹4.74 Cr | ₹-12 Cr | ₹3.79 Cr |
What is the latest Consolidated Net Profit of BAL PHARMA ?
Year | Consolidated Net Profit |
---|---|
Mar2023 | ₹2.57 Cr |
Mar2022 | ₹5.61 Cr |
Mar2021 | ₹4.74 Cr |
Mar2020 | ₹-12 Cr |
Mar2019 | ₹3.79 Cr |
How is Consolidated Net Profit of BAL PHARMA Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2023 | ₹2.57 Cr | -54.17 | |
Mar2022 | ₹5.61 Cr | 18.35 | |
Mar2021 | ₹4.74 Cr | Positive | |
Mar2020 | ₹-12 Cr | Negative | |
Mar2019 | ₹3.79 Cr | - |
Compare Consolidated Net Profit of peers of BAL PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
BAL PHARMA | ₹159.8 Cr | 0.1% | 2.5% | 27.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹365,167.0 Cr | 2.6% | -4.7% | 54.7% | Stock Analytics | |
CIPLA | ₹113,645.0 Cr | 4.4% | -4.4% | 54.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹105,890.0 Cr | 5.8% | 17.7% | 24.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,987.0 Cr | 5.7% | 2.7% | 29.3% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹96,950.6 Cr | 0.4% | -5.4% | 82.7% | Stock Analytics |
BAL PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
BAL PHARMA | 0.1% |
2.5% |
27.1% |
SENSEX | 1.4% |
2.5% |
24.3% |
You may also like the below Video Courses